Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study

Treatment of cognitive impairment in patients with multiple sclerosis

(2012) Francesco Patti   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Multiple sclerosis: Neuroprotective alliance of estrogen–progesterone and gender

(2012) Markus Kipp et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Cognitive deterioration in patients with early multiple sclerosis: a 5-year study

(2011) Bonnie I Glanz et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis

(2011) M Calabrese et al.   Multiple Sclerosis Journal

The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment

(2011) Sabine Lindquist et al.   Multiple Sclerosis Journal

Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis

(2010) F. Reuter et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients

(2010) RA Rudick et al.   Multiple Sclerosis Journal

Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis

(2009) Massimiliano Calabrese et al.   ARCHIVES OF NEUROLOGY

Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment

(2009) M. Trojano et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis

(2009) F. Patti et al.   Multiple Sclerosis Journal

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study

(2009) F Patti et al.   Multiple Sclerosis Journal

Memory decline evolves independently of disease activity in MS

(2008) B Duque et al.   Multiple Sclerosis Journal

Cognitive impairment in multiple sclerosis

(2008) F Patti   Multiple Sclerosis Journal

Temporal trends in the incidence of multiple sclerosis: A systematic review

(2008) A. Alonso et al.   NEUROLOGY